This inventor holds 1 USPTO granted patent. Top assignees: Agency for Science, Technology and Research, Euchloe Bio Pte. Ltd.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,561 
1 out of 1 Years Active: 2023
Title: Cheng-l Wang: Innovator in Antigen Binding Molecules
Introduction
Cheng-l Wang is a notable inventor based in Singapore, recognized for his contributions to the field of biotechnology. He has developed innovative antigen binding molecules that have significant implications in medical research and treatment.
Latest Patents
Wang holds a patent for "IL2Rbeta/common gamma chain antibodies." This patent discloses antigen binding molecules capable of binding to CD122 and/or the common gamma chain (CD132). Additionally, it includes compositions comprising such antigen binding molecules, along with various uses and methods utilizing these innovations.
Career Highlights
Throughout his career, Cheng-l Wang has worked with prominent organizations, including the Agency for Science, Technology and Research and Euchloe Bio Pte. Ltd. His work in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Wang has collaborated with esteemed colleagues such as Peter Brauer and John Edward Connolly, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Cheng-l Wang's innovative work in antigen binding molecules exemplifies the importance of research and development in biotechnology. His contributions continue to influence the field and pave the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile